You are here

Germany to buy stake in biotech firm CureVac

Frankfurt

GERMANY will take a stake in unlisted biotech firm CureVac, which is working on a Covid-19 vaccine, Economy Minister Peter Altmaier said on Monday, confirming an earlier Reuters report.

The Berlin government will acquire a 23 per cent stake for 300 million euros (S$470.6...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes